-
2025-520565-51-00
5
small cell lung cancer
-
2024-517968-36-00
5
2025-07-08
non-small cell lung cancer
-
2023-506235-15-00
5
2024-11-07
Limited-Stage Small-Cell Lung Cancer (LS SCLC)
-
2023-505606-42-00
5
2024-10-15
Head and Neck Squamous Cell Carcinoma (HNSCC)
-
2023-504247-13-00
4
2023-10-17
Large cell neuroendocrine carcinoma
-
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
-
2024-519369-24-00
5
2026-01-29
METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
-
2025-521281-97-00
5
2025-12-02
Non-Small Cell Lung Cancer (NSCLC)
-
2025-521511-40-00
10
2025-11-18
metastatic non-small cell lung cancer
-
2024-517780-24-00
5
2025-09-18
Lung Cancer
-
2024-515698-85-00
5
2025-06-12
Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
2023-506327-29-00
5
2025-05-14
Non-Small Cell Lung Cancer
-
2023-507776-42-00
5
2024-11-14
Non-small cell lung cancer
-
2024-511319-91-00
5
2024-10-23
Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-505871-63-00
5
2024-04-08
ER+, HER2- metastatic breast cancer following endocrine and CDK 4/6 in
-
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-513621-23-00
5
2025-04-18
Advanced/metastatic non-small cell lung cancer (NSCLC)
-
2024-515538-34-00
10
2025-02-27
Head and Neck Squamous Cell Carcinoma
-
2023-505989-29-00
5
2024-11-21
Extensive stage small cell lung cancer (ES-SCLC)
-
2023-503575-21-00
5
2024-01-23
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
-
2022-501622-37-00
5
2024-01-16
Multiple Sclerosis
-
2023-505023-31-00
5
2023-11-17
Renal cell carcinoma